Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling

Physiological Reviews - United States
doi 10.1152/physrev.00024.2015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Physiological Society

Related search

Evolution of Acquired Resistance to Anti-Cancer Therapy

Journal of Theoretical Biology
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology SimulationImmunologyBiological SciencesMedicineAgriculturalModeling
2014English

Acquired Resistance to Cancer Chemotherapy.

BMJ
1984English

Emergence of KRAS Mutations and Acquired Resistance to Anti-Egfr Therapy in Colorectal Cancer

Nature
Multidisciplinary
2012English

Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer

Cancer Research
Cancer ResearchOncology
2016English

PAK Signaling Promotes Acquired Resistance to BRAF and MEK Inhibitors

Cancer Discovery
Oncology
2017English

Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

JAMA Oncology
Cancer ResearchOncology
2018English

Twist Contributes to Hormone Resistance in Breast Cancer by Downregulating Estrogen Receptor-Α

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Activation of the Met Kinase Confers Acquired Drug Resistance in FGFR-targeted Lung Cancer Therapy

Oncogenesis
Cancer ResearchMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy